Covington Capital Management’s AstraZeneca AZN Stock Holding History

Covington Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$208K	Sell	1,898 -25	-1%	-$3.17K	0.01%	354
2022 Q2	$254K	Hold	1,923	–	–	0.01%	339
2022 Q1	$255K	Buy	1,923 +25	+1%	+$3K	0.01%	350
2021 Q4	$221K	Hold	1,898	–	–	0.01%	343
2021 Q3	$228K	Buy	1,898 +1,148	+153%	+$134K	0.01%	345
2021 Q2	$90K	Hold	750	–	–	﹤0.01%	462
2021 Q1	$75K	Hold	750	–	–	﹤0.01%	436
2020 Q4	$75K	Hold	750	–	–	﹤0.01%	426
2020 Q3	$82K	Hold	750	–	–	﹤0.01%	401
2020 Q2	$79K	Hold	750	–	–	﹤0.01%	395
2020 Q1	$67K	Hold	750	–	–	﹤0.01%	384
2019 Q4	$75K	Hold	750	–	–	﹤0.01%	412
2019 Q3	$67K	Hold	750	–	–	﹤0.01%	399
2019 Q2	$62K	Hold	750	–	–	﹤0.01%	405
2019 Q1	$61K	Sell	750 -450	-38%	-$35.5K	﹤0.01%	396
2018 Q4	$91K	Buy	1,200 +1,100	+1,100%	+$85.9K	0.01%	340
2018 Q3	$8K	Hold	100	–	–	﹤0.01%	618
2018 Q2	$7K	Buy	+100	New	+$7.19K	﹤0.01%	644

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Covington Capital Management's AZN Position: Q3 2022 in Review

Covington Capital Management reduced its AstraZeneca (AZN) stake by 1.3% in Q3 2022, selling an estimated $3.17K and leaving 1,898 shares worth $208K. The position accounts for 0.01% of the portfolio, ranked #354.

Covington Capital Management first reported a position in AZN in Q2 2018 and has held it in 18 quarters since. The position peaked at $255K in Q1 2022. 966 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

Covington Capital Management held 1,898 shares of AstraZeneca worth $208K as of Q3 2022.
Covington Capital Management sold 25 AstraZeneca shares in Q3 2022, an estimated $3.17K.
AstraZeneca made up 0.01% of Covington Capital Management's portfolio in Q3 2022, its #354 holding.
Covington Capital Management first reported a position in AstraZeneca in Q2 2018 and has held it in 18 quarters since.
Covington Capital Management's AstraZeneca position peaked at $255K in Q1 2022.
966 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.